M C Cripps

Author PubWeight™ 36.15^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.	J Clin Oncol	1997	29.02
2	A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.	Ann Oncol	1996	4.07
3	Cancer physicians' attitudes toward colorectal cancer follow-up.	Ann Oncol	2003	0.88
4	The estrogen receptor test: a prognostic tool in primary breast cancer.	Can J Surg	1982	0.78
5	Duration of intravenous antibiotics for patients with neutropenic fever.	Ann Oncol	1994	0.78
6	Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma.	N Engl J Med	1993	0.77
7	Pilot study of multiple chemotherapy resistance modulators plus epirubicin in the treatment of resistant malignancies.	Cancer Chemother Pharmacol	1997	0.75
8	Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study.	Invest New Drugs	1997	0.75
9	Doxorubicin plus metronidazole in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck.	Am J Clin Oncol	1993	0.75
10	Cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of squamous cell carcinoma of the head and neck.	Am J Clin Oncol	1993	0.75
11	Effects of PALA on the pharmacokinetics of 5-fluorouracil.	Oncol Rep	1998	0.75